VYCOR MEDICAL INC (VYCO)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 12-31. Amounts in USD.

Revenue TTM

0 700K 1.4M 2.1M Q3 '24: 1.4M Q4 '24: 1.6M Q1 '25: 1.7M Q2 '25: 1.8M Q3 '25: 1.9M Q4 '25: 1.9M Q1 '26: 1.9M Q2 '26: 1.8M Q3 '24 Q4 '24 Q1 '25 Q2 '25 Q3 '25 Q4 '25 Q1 '26 Q2 '26

Gross Profit TTM

0 600K 1.2M 1.8M Q3 '24: 1.3M Q4 '24: 1.4M Q1 '25: 1.5M Q2 '25: 1.5M Q3 '25: 1.6M Q4 '25: 1.6M Q1 '26: 1.6M Q2 '26: 1.5M Q3 '24 Q4 '24 Q1 '25 Q2 '25 Q3 '25 Q4 '25 Q1 '26 Q2 '26

Operating Income TTM

-105K -70K -35K 0 35K 70K 105K Q3 '24: -92.5K Q4 '24: -9.1K Q1 '25: -12.4K Q2 '25: 22.5K Q3 '25: 89.8K Q4 '25: 33.9K Q1 '26: 92.5K Q2 '26: 48.2K Q3 '24 Q4 '24 Q1 '25 Q2 '25 Q3 '25 Q4 '25 Q1 '26 Q2 '26

Net Income TTM

-210K -140K -70K 0 70K 140K 210K Q3 '24: -193.5K Q4 '24: -107.2K Q1 '25: -115.2K Q2 '25: -81.2K Q3 '25: -16.5K Q4 '25: -72.4K Q1 '26: -13.8K Q2 '26: -59.9K Q3 '24 Q4 '24 Q1 '25 Q2 '25 Q3 '25 Q4 '25 Q1 '26 Q2 '26

Cost of Revenue TTM

0 150K 300K 450K Q3 '24: 151K Q4 '24: 166.8K Q1 '25: 207.6K Q2 '25: 253.6K Q3 '25: 278.6K Q4 '25: 302.3K Q1 '26: 307.8K Q2 '26: 300.6K Q3 '24 Q4 '24 Q1 '25 Q2 '25 Q3 '25 Q4 '25 Q1 '26 Q2 '26

Operating Cash Flow TTM

-40K 0 40K 80K 120K Q3 '23: -9.4K Q4 '23: 29.4K Q1 '24: 6.7K Q2 '24: 78.6K Q3 '24: 103.9K Q4 '25: -13.5K Q1 '26: 112.9K Q2 '26: 61.4K Q3 '23 Q4 '23 Q1 '24 Q2 '24 Q3 '24 Q4 '25 Q1 '26 Q2 '26

Free Cash Flow TTM

-450K -300K -150K 0 150K 300K 450K Q1 '20: -115.8K Q2 '20: -152K Q3 '20: -329.6K Q4 '20: -310.8K Q1 '21: -287.7K Q2 '21: -161.7K Q3 '21: -56.6K Q4 '21: -17K Q1 '20 Q2 '20 Q3 '20 Q4 '20 Q1 '21 Q2 '21 Q3 '21 Q4 '21

Operating cash flow minus capital expenditure.

Shares Outstanding Quarterly

0 15M 30M 45M Q1 '24: 32.6M Q2 '24: 32.6M Q3 '24: 32.9M Q1 '25: 33.4M Q2 '25: 38.7M Q3 '25: 33.4M Q1 '26: 33.4M Q2 '26: 33.4M Q1 '24 Q2 '24 Q3 '24 Q1 '25 Q2 '25 Q3 '25 Q1 '26 Q2 '26

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

-0.04 -0.03 -0.01 0.00 0.01 0.03 0.04 Q3 '20: -0.04 Q4 '20: -0.03 Q1 '21: -0.03 Q2 '21: -0.02 Q1 '23: -0.01 Q2 '23: -0.01 Q1 '26: 0.00 Q2 '26: 0.00 Q3 '20 Q4 '20 Q1 '21 Q2 '21 Q1 '23 Q2 '23 Q1 '26 Q2 '26

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.